Scholarlink

Objective <p>To investigate the anti-inflammatory properties of anti-seizure medications (ASMs) administered to patients with drug-resistant epilepsy (DRE) and the role of sodium channels in microglial activation.</p> Material <p>Primary microglia monocultures from mice brains.</p> Treatment <p>Microglia were activated with 10&#xa0;μg/mL lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C) and pre- (45&#xa0;min ASM then 2&#xa0;h ASM plus stimulus) or post- (2&#xa0;h stimulus then 24&#xa0;h only ASM) treated with ASMs. Microglia were treated with cannabidiol (10&#xa0;μM), stiripentol (250&#xa0;μM), fenfluramine (50&#xa0;μM), phenytoin (8 and 40&#xa0;μM), cenobamate (300 and 900&#xa0;μM), or the small molecule sodium channel blocker GS967 (10 and 30&#xa0;μM). The sodium channel modulators tetrodotoxin (1&#xa0;μM), µ-conotoxin KIIIA (1&#xa0;μM), and β-pompilidotoxin (0.5&#xa0;μM) were also applied.</p> Methods <p>Microglia activation was quantified through measurements of <i>Ptgs2</i> (<i>Cox2</i>), <i>Tnf-α</i>, and <i>Ifn-β</i> induction by RT-qPCR and of cell morphology by immunocytochemistry. Expression of sodium channels in microglia was studied using PCR, RT-qPCR, immunohisto- and immunocytochemistry. Mann Whitney test and the Kruskal–Wallis test with Dunn’s multiple comparisons post-test were used.</p> Results <p>ASMs have a differential effect on microglial activation. Uniquely, cenobamate inhibited the induction of <i>Ifn-β</i> and made the cells less amoeboid. The voltage gated sodium channel Na<sub>v</sub>1.2 is expressed by microglial cells and its expression levels change with microglial inflammatory response. Toxins that block sodium channels modulated microglial activation.</p> Conclusions <p>ASMs, applied to patients with DRE, have a differential ability to reduce microglial activation and pro-inflammatory microglial morphology in vitro. Moreover, sodium channel blockage modulates inflammation through microglia activation. Taken together these results suggest, that further investigation of patient’s immune response to ASMs could be important.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Microglial activation is inhibited by selective anti-seizure medications

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月23日

查看全文
  • Robert Jürgen Platow,
  • Sabrina Pommer,
  • Julia Brauer,
  • Yanyan Wang,
  • Shyamala Mani,
  • Angela M. Kaindl

摘要

Objective

To investigate the anti-inflammatory properties of anti-seizure medications (ASMs) administered to patients with drug-resistant epilepsy (DRE) and the role of sodium channels in microglial activation.

Material

Primary microglia monocultures from mice brains.

Treatment

Microglia were activated with 10 μg/mL lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C) and pre- (45 min ASM then 2 h ASM plus stimulus) or post- (2 h stimulus then 24 h only ASM) treated with ASMs. Microglia were treated with cannabidiol (10 μM), stiripentol (250 μM), fenfluramine (50 μM), phenytoin (8 and 40 μM), cenobamate (300 and 900 μM), or the small molecule sodium channel blocker GS967 (10 and 30 μM). The sodium channel modulators tetrodotoxin (1 μM), µ-conotoxin KIIIA (1 μM), and β-pompilidotoxin (0.5 μM) were also applied.

Methods

Microglia activation was quantified through measurements of Ptgs2 (Cox2), Tnf-α, and Ifn-β induction by RT-qPCR and of cell morphology by immunocytochemistry. Expression of sodium channels in microglia was studied using PCR, RT-qPCR, immunohisto- and immunocytochemistry. Mann Whitney test and the Kruskal–Wallis test with Dunn’s multiple comparisons post-test were used.

Results

ASMs have a differential effect on microglial activation. Uniquely, cenobamate inhibited the induction of Ifn-β and made the cells less amoeboid. The voltage gated sodium channel Nav1.2 is expressed by microglial cells and its expression levels change with microglial inflammatory response. Toxins that block sodium channels modulated microglial activation.

Conclusions

ASMs, applied to patients with DRE, have a differential ability to reduce microglial activation and pro-inflammatory microglial morphology in vitro. Moreover, sodium channel blockage modulates inflammation through microglia activation. Taken together these results suggest, that further investigation of patient’s immune response to ASMs could be important.